Avecho Biotechnology LimitedASX: AVE

Avecho completes treatment for Phase III interim analysis

· Issued by Avecho Biotechnology Limited

Avecho Biotechnology Limited has released a press release.

View Attachment

Earlier from Avecho Biotechnology

All Avecho Biotechnology news releases